Mapping the minimal murine T cell and B cell epitopes within a peptide vaccine candidate from the conserved region of the M protein of group A streptococcus

International Immunology
W A HaymanM F Good

Abstract

The highly conserved C-terminus of the M protein of group A streptococcus (GAS) is a promising vaccine candidate. An epitope within the conserved C-terminus of the M protein, peptide 145 (a 20-mer with the sequence: LRRDLDASREAKKQVEKALE), has been defined which is the target of opsonic antibodies in both humans and mice, and is recognized by the sera of most adults living in areas of high streptococcal exposure. However, due to potential cross-reactivity between T cells stimulated by this region of the M protein and host cardiac myosin, it is critical to define precisely the minimal protective epitopes within p145. Studies have shown that the immunodominant epitope expressed by p145 is conformational, occurring as an alpha-helical coiled-coil. To enable us to map the murine minimal B cell and T cell epitopes within p145, we have used a novel strategy that allowed us to present shorter sequences of p145 in a native-like conformation. The minimal B cell epitope was found to be contained within residues 7-20 of the p145 sequence, and we have shown that mice immunized with this region are able to generate antibodies that bind to and also opsonize the organism GAS. The T cell epitope is located at the N-terminal region of the p145 s...Continue Reading

Citations

Dec 13, 2006·Clinical & Developmental Immunology·L GuilhermeJ Kalil
Jun 22, 1999·Immunologic Research·E R Brandt, M F Good
Apr 12, 2002·International Journal for Parasitology·Michael F GoodMichael Batzloff
Jul 17, 2007·Epidemiology and Infection·A C SteerJ R Carapetis
Oct 20, 2012·Clinical and Vaccine Immunology : CVI·Therese NordströmMichael R Batzloff
Oct 12, 2012·PloS One·Mariusz SkwarczynskiIstvan Toth
Nov 13, 2009·Expert Review of Vaccines·Pierre R SmeestersMelina M Georgousakis
Aug 11, 2010·The American Journal of the Medical Sciences·Michael S Bronze, James B Dale
Feb 23, 2013·Nanomedicine : Nanotechnology, Biology, and Medicine·Peter M MoyleIstvan Toth
Nov 3, 2010·Nanomedicine : Nanotechnology, Biology, and Medicine·Mehfuz ZamanIstvan Toth
Jul 28, 2005·Tropical Medicine & International Health : TM & IH·Hermann FeldmeierHumberto Guerra
Apr 12, 2016·Acta Biomaterialia·Khairunnisa Abdul GhaffarIstvan Toth
Jun 10, 2011·Vaccine·Anton P J MiddelbergMichael R Batzloff
Dec 21, 2014·The AAPS Journal·Amanda TrentMatthew V Tirrell
Jun 24, 2015·Journal of Immunology Research·Shu Ki TsoiAndrew C Steer
Jul 19, 2013·Human Vaccines & Immunotherapeutics·Michael F GoodManisha Pandey
Dec 20, 2012·Human Vaccines & Immunotherapeutics·Ivette Caro-AguilarJulie M Skinner
Aug 20, 2016·Human Vaccines & Immunotherapeutics·Michael R BatzloffMichael F Good

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.